Boston, MA -- (SBWIRE) -- 03/01/2017 -- GlobalData's new report, "United States Diabetes Care Devices Market Outlook to 2022", provides key market data on the United States Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Report Scope

Get More Details on this Report and a Full Table of Contents at United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

-Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.

-Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.

-2015 company shares and distribution shares data for Diabetes Care Devices market.

-Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices market.

-Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to Get this Report

-Develop business strategies by identifying the key market segments poised for strong growth in the future.

-Develop market-entry and market expansion strategies.

-Design competition strategies by identifying who-stands-where in the market.

-Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

-What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: Medtronic plc, Eli Lilly and Company, LifeScan Inc, Becton Dickinson and Co, Bayer HealthCare AG, Novo Nordisk A/S, Abbott Laboratories, Insulet Corp, DexCom Inc, F. Hoffmann-La Roche Ltd, Sanofi, Trividia Health Inc

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

-United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery
-India Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery
-Canada Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery
-Germany Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery
-Australia Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery